Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H22N6O4.Cu |
| Molecular Weight | 401.908 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cu++].NCCCC[C@H](NC(=O)[C@H](CC1=C[N-]C=N1)NC(=O)CN)C([O-])=O
InChI
InChIKey=QMIFIFIYYPUVNU-ACMTZBLWSA-L
InChI=1S/C14H24N6O4.Cu/c15-4-2-1-3-10(14(23)24)20-13(22)11(19-12(21)6-16)5-9-7-17-8-18-9;/h7-8,10-11H,1-6,15-16H2,(H4,17,18,19,20,21,22,23,24);/q;+2/p-2/t10-,11-;/m0./s1
| Molecular Formula | Cu |
| Molecular Weight | 63.546 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C14H24N6O4 |
| Molecular Weight | 340.3782 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Prezatide is a tripeptide molecule consisiting of lysine, glycine and histidine, also known as GHK (glycyl-L-histidyl-L-lysine), that forms a complex with copper ions. Prezatide is used in cosmetic products (skin and hair) and is known help wound healing. Prezatide increases the synthesis and deposition of type I collagen and glycosaminoglycan. It is thought to play a role in the modulation of tissue remodeling by increases the expression of matrix metalloproteinase-2, as well as tissue inhibitor of matrix metalloproteinases-1 and -2. Prezatide has antioxidant activity due to its ability to supply copper for superoxide dismutase and anti-inflammatory ability due to the blockage the of iron (Fe2+) release during injury.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 17 06:47:34 UTC 2022
by
admin
on
Sat Dec 17 06:47:34 UTC 2022
|
| Record UNII |
6BJQ43T1I9
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB14683
Created by
admin on Sat Dec 17 06:47:34 UTC 2022 , Edited by admin on Sat Dec 17 06:47:34 UTC 2022
|
PRIMARY | |||
|
DTXSID20237492
Created by
admin on Sat Dec 17 06:47:34 UTC 2022 , Edited by admin on Sat Dec 17 06:47:34 UTC 2022
|
PRIMARY | |||
|
6BJQ43T1I9
Created by
admin on Sat Dec 17 06:47:34 UTC 2022 , Edited by admin on Sat Dec 17 06:47:34 UTC 2022
|
PRIMARY | |||
|
10111685
Created by
admin on Sat Dec 17 06:47:34 UTC 2022 , Edited by admin on Sat Dec 17 06:47:34 UTC 2022
|
PRIMARY | |||
|
89030-95-5
Created by
admin on Sat Dec 17 06:47:34 UTC 2022 , Edited by admin on Sat Dec 17 06:47:34 UTC 2022
|
PRIMARY | |||
|
1314233
Created by
admin on Sat Dec 17 06:47:34 UTC 2022 , Edited by admin on Sat Dec 17 06:47:34 UTC 2022
|
PRIMARY | RxNorm | ||
|
M5722
Created by
admin on Sat Dec 17 06:47:34 UTC 2022 , Edited by admin on Sat Dec 17 06:47:34 UTC 2022
|
PRIMARY | Merck Index | ||
|
6BJQ43T1I9
Created by
admin on Sat Dec 17 06:47:34 UTC 2022 , Edited by admin on Sat Dec 17 06:47:34 UTC 2022
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |